172 related articles for article (PubMed ID: 16026789)
1. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups.
Jaouad L; de Guise C; Berrougui H; Cloutier M; Isabelle M; Fulop T; Payette H; Khalil A
Atherosclerosis; 2006 Mar; 185(1):191-200. PubMed ID: 16026789
[TBL] [Abstract][Full Text] [Related]
2. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
[TBL] [Abstract][Full Text] [Related]
3. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
[TBL] [Abstract][Full Text] [Related]
4. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
5. PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity.
Jaouad L; Milochevitch C; Khalil A
Free Radic Res; 2003 Jan; 37(1):77-83. PubMed ID: 12653220
[TBL] [Abstract][Full Text] [Related]
6. Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities.
Loued S; Berrougui H; Componova P; Ikhlef S; Helal O; Khalil A
Br J Nutr; 2013 Oct; 110(7):1272-84. PubMed ID: 23510814
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins.
Loued S; Isabelle M; Berrougui H; Khalil A
Life Sci; 2012 Jan; 90(1-2):82-8. PubMed ID: 22067439
[TBL] [Abstract][Full Text] [Related]
8. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
10. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
Obesity (Silver Spring); 2010 Jun; 18(6):1079-84. PubMed ID: 19834469
[TBL] [Abstract][Full Text] [Related]
11. Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration.
Baskol G; Karakucuk S; Oner AO; Baskol M; Kocer D; Mirza E; Saraymen R; Ustdal M
Ophthalmologica; 2006; 220(1):12-6. PubMed ID: 16374043
[TBL] [Abstract][Full Text] [Related]
12. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
[TBL] [Abstract][Full Text] [Related]
13. Study of factors influencing the decreased HDL associated PON1 activity with aging.
Seres I; Paragh G; Deschene E; Fulop T; Khalil A
Exp Gerontol; 2004 Jan; 39(1):59-66. PubMed ID: 14724065
[TBL] [Abstract][Full Text] [Related]
14. Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men.
Cherki M; Derouiche A; Drissi A; El Messal M; Bamou Y; Idrissi-Ouadghiri A; Khalil A; Adlouni A
Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):352-60. PubMed ID: 16216721
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
16. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
[TBL] [Abstract][Full Text] [Related]
17. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation.
Mehdi MM; Rizvi SI
Arch Med Res; 2012 Aug; 43(6):438-43. PubMed ID: 22959975
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Samy W; Hassanian MA
Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
[TBL] [Abstract][Full Text] [Related]
19. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Hashim Z; Zarina S
Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
[TBL] [Abstract][Full Text] [Related]
20. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.
Nguyen SD; Sok DE
Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
